Trafalgar International GCAN
OTC GCAN
$0.35 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Trafalgar International (GCAN) EBITDA Margin (2017 - 2021)

Trafalgar International (GCAN) posted EBITDA Margin of 494.65% for Q2 2021, down 190.16% on a QoQ basis from 170.47% in Q2 2020, and down 32417.0% year-over-year from N/an in Q2 2020.

Analysis

Trafalgar International (GCAN) EBITDA Margin (2017 - 2021) Analysis & Trends

Trafalgar International has reported EBITDA Margin for 5 years, with the latest figure at 494.65% in Q2 2021.

  • On a quarterly basis, EBITDA Margin fell 32417.0% year-over-year to 494.65% in Q2 2021; TTM through Dec 2021 was 2716.91%, a 215651.0% decrease from a year earlier, with the FY2021 full-year figure at 2716.91%, down 210402.0% from the prior year.
  • EBITDA Margin was 494.65% for Q2 2021 at Trafalgar International, down from 170.47% in the prior quarter.
  • The five-year high for EBITDA Margin was 99.52% in Q1 2018, with the low at 43656.16% in Q2 2017.
  • Average EBITDA Margin over 5 years is 10037.53%, with a median of 1744.25% recorded in 2019.
  • The sharpest annual moves came in 2018 and 2021: EBITDA Margin surged 4375550 bps in 2018, then tumbled 32417 bps in 2021.
  • Over 5 years, EBITDA Margin stood at 28856.62% in 2017, then surged by 100 bps to 99.34% in 2018, then plunged by 4456 bps to 4327.33% in 2019, then surged by 96 bps to 170.47% in 2020, then sank by 190 bps to 494.65% in 2021.
  • The last three EBITDA Margin figures came in at 494.65% (Q2 2021), 170.47% (Q2 2020), and 4327.33% (Q4 2019), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Johnson & Johnson 642.00 Bn 621.25 Bn 17.26 Bn 28.21%
2 AbbVie 446.05 Bn 439.48 Bn 12.70 Bn 37.86%
3 Merck 357.71 Bn 350.56 Bn 12.21 Bn -3.52%
4 Novartis Ag 268.09 Bn 260.40 Bn 11.24 Bn 32.97%
5 Pfizer 156.78 Bn 145.08 Bn 10.94 Bn 28.37%
6 Sanofi 52.12 Bn 44.74 Bn 10.79 Bn 9.03%
7 Revolution Medicines 43.05 Bn 43.05 Bn - -
8 Incyte 24.84 Bn 20.31 Bn 1.57 Bn 41.69%
9 United Therapeutics 21.39 Bn 18.73 Bn 683.80 Mn 42.23%
10 Trafalgar International 217,335.05 217,335.05 - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 -494.65%
Jun 30, 2020 -170.47%
Dec 31, 2019 -4,327.33%
Sep 30, 2019 -2,993.85%
Jun 30, 2018 99.34%
Mar 31, 2018 99.52%
Sep 30, 2017 -28,856.62%
Jun 30, 2017 -43,656.16%